Evidence map›Paper›PMID 38566249›Full record

ArticleAddiction science & clinical practice2024

Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study.

Iván D Montoya, Colleen Watson, Arnie Aldridge, Danielle Ryan, Sean M Murphy, Brenda Amuchi, Kathryn E McCollister, Bruce R Schackman, Joshua L Bush, Drew Speer and 8 more

Open access · goldAbstract read
In one paragraph

Article in Addiction science & clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Iván D MontoyaDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Colleen WatsonRTI International, Research Triangle Park, NC, USA.
Arnie AldridgeRTI International, Research Triangle Park, NC, USA.
Danielle RyanDepartment of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.
Sean M MurphyDepartment of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.
Brenda AmuchiSection of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
Kathryn E McCollisterDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Bruce R SchackmanDepartment of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.
Joshua L BushCollege of Public Health, University of Kentucky, Lexington, KY, USA.
Drew SpeerCollege of Public Health, University of Kentucky, Lexington, KY, USA.
Kristin HarlowCollege of Public Health, The Ohio State University, Columbus, OH, USA.
Stephen OrmeRTI International, Research Triangle Park, NC, USA.
Gary A ZarkinRTI International, Research Triangle Park, NC, USA.
Mathieu CastrySection of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
Eric E SeiberCollege of Public Health, The Ohio State University, Columbus, OH, USA.
Joshua A BarocasSections of General Internal Medicine and Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Benjamin P LinasSection of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
Laura E StarbirdDepartment of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, PA, USA. starbird@nursing.upenn.edu.ORCID 0000-0003-4056-2422
RTI International · USBoston University · USCornell University · USThe Ohio State University · USUniversity of Kentucky · USUniversity of Miami · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania · US

Funding

MassHEAL - Reducing overdose deaths by 40% (2019-2023)UM1DA049412 · NIDA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2019 to 2023
$82.9M
Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)UM1DA049406 · NIDA · UNIVERSITY OF KENTUCKY · PI WALSH, SHARON L. · 2019 to 2022
$81.7M
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York StateUM1DA049415 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, GILBERT, LOUISA · 2019 to 2023
$77.3M
Optimizing HEALing in Ohio Communities (OHiO)-Health Equity SupplementUM1DA049417 · NIDA · OHIO STATE UNIVERSITY · PI FREISTHLER, BRIDGET J, WINHUSEN, T JOHN · 2019 to 2023
$66.3M
HEALing Communities Study Health Equity ResearchUM1DA049394 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI GLASGOW, LASHAWN, KNOTT, CHARLES · 2019 to 2023
$40.6M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Implementation of PrEP for Women Who Inject Drugs through Practice Facilitation in Primary and Reproductive Health CareK01DA051348 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI STARBIRD, LAURA · 2020 to 2024
$962k
NIDA NIH HHS K01 DA051348NIDA NIH HHS T32 DA037801NIDA NIH HHS UM1 DA049394NIDA NIH HHS UM1 DA049406NIDA NIH HHS UM1 DA049412NIDA NIH HHS UM1 DA049415NIDA NIH HHS UM1 DA049417SAMHSA HHS UM1DA049394SAMHSA HHS UM1DA049406SAMHSA HHS UM1DA049412SAMHSA HHS UM1DA049415SAMHSA HHS UM1DA049417
6 · The paper itself

Abstract

backgroundCommunities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based practices, and delivering a communications campaign across healthcare, behavioral-health, criminal-legal, and other community-based settings. The implementation of such a complex initiative requires up-front investments of time and other expenditures (i.e., start-up costs). Despite the importance of these start-up costs in investment decisions to stakeholders, they are typically excluded from cost-effectiveness analyses. The objective of this study is to report a detailed analysis of CTH start-up costs pre-intervention implementation and to describe the relevance of these data for stakeholders to determine implementation feasibility.

methodsThis study is guided by the community perspective, reflecting the investments that a real-world community would need to incur to implement the CTH intervention. We adopted an activity-based costing approach, in which resources related to hiring, training, purchasing, and community dashboard creation were identified through macro- and micro-costing techniques from 34 communities with high rates of fatal opioid overdoses, across four states-Kentucky, Massachusetts, New York, and Ohio. Resources were identified and assigned a unit cost using administrative and semi-structured-interview data. All cost estimates were reported in 2019 dollars.

resultsState-level average and median start-up cost (representing 8-10 communities per state) were $268,657 and $175,683, respectively. Hiring and training represented 40%, equipment and infrastructure costs represented 24%, and dashboard creation represented 36% of the total average start-up cost. Comparatively, hiring and training represented 49%, purchasing costs represented 18%, and dashboard creation represented 34% of the total median start-up cost.

conclusionWe identified three distinct CTH hiring models that affected start-up costs: hospital-academic (Massachusetts), university-academic (Kentucky and Ohio), and community-leveraged (New York). Hiring, training, and purchasing start-up costs were lowest in New York due to existing local infrastructure. Community-based implementation similar to the New York model may have lower start-up costs due to leveraging of existing infrastructure, relationships, and support from local health departments.

Indexed as

Opiate OverdoseDelivery of Health CareEvidence-Based PracticeHumansMassachusettsCommunity engagementCost analysisIntervention implementationOpioid use disorderStart-up cost

Identifiers

PMID38566249
PMCPMC10988809
OpenAlexW4393579085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.